Chairman Towns Announces Hearing to Examine Recall of Popular Pediatric Medicines

Chairman Towns Announces Hearing to Examine Recall of Popular Pediatric Medicines
WASHINGTON - Chairman Edolphus "Ed" Towns (D-NY) today announced that the House Committee on Oversight and Government Reform will hold a hearing on Thursday, May 27, 2010 to examine the circumstances surrounding the voluntary recall of popular infant and children's medicines produced by Johnson & Johnson/McNeil Consumer Healthcare.  On May 5, 2010, Chairman Towns and Ranking Member Darrell Issa (R-CA) opened the committee's investigation into the circumstances surrounding the voluntary recall of such widely used pediatric medications as Children's Tylenol, Infants' Tylenol, Children's Motrin, and Children's Benadryl.

The hearing will take place at 10:00 a.m. in room 2154 Rayburn House Office Building.  The witnesses invited to testify are:

Dr. Joshua M. Sharfstein
Principal Deputy Commissioner
U.S. Food & Drug Administration

Ms. Colleen Goggins
Worldwide Chairman
Johnson & Johnson Consumer Group